Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Abarelix: a promising new treatment option for patients with prostate cancer

June 12, 1998

More on Ilex Oncology's chemopreventive agent

June 11, 1998

Duke University pioneers novel therapy for GBM

June 11, 1998

Vapreotide, RC-3940-II and cetrorelix: novel peptide analogues for treating renal cell carcinoma

June 11, 1998

Miravant and Xillix Technologies enter early-stage cancer collaboration

June 10, 1998

GlycoDesign starts phase II trial of GD0039 for the treatment of RCC

June 10, 1998

Clinical trial results for DUROS leuprolide implant announced at AUA meeting

June 10, 1998

No-approval recommendation given for AD-32 by FDA advisory committee

June 9, 1998

Antitumor, antifungal cryptophycins developed by U.S. pharmaceutical/academic team

June 9, 1998

BMS prepares novel sulfenamide taxane derivatives

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.